BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

  Crinetics Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2023.

  May 4, 2023

   · 

  10 min read
• Business

  Sight Sciences Reports First Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023

  Sight Sciences, Inc., an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, reported financial results for the first quarter ended March 31, 2023 and reaffirmed guidance for full year 2023.

  May 4, 2023

   · 

  11 min read
• Business

  Vaxart Provides Business Update and Reports First Quarter 2023 Financial Results

  Vaxart, Inc. announced its business update and financial results for the first quarter of 2023.

  May 4, 2023

   · 

  10 min read
• Business

  NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data

  NGM Biopharmaceuticals, Inc., a clinical-stage biotechnology company focused on discovering and developing transformative therapeutics for patients, reported financial results for the quarterly period ended March 31, 2023 and provided business highlights.

  May 4, 2023

   · 

  11 min read
• Business

  Curis Provides First Quarter 2023 Business Update

  Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported its business update and financial results for the first quarter ended March 31, 2023.

  May 4, 2023

   · 

  12 min read
• Business

  Heron Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

  Heron Therapeutics, Inc. announced that the company will host a conference call and live webcast on Thursday, May 11, 2023 at 4:30 p.m. ET to report first quarter 2023 financial results and discuss recent business highlights.

  May 4, 2023

   · 

  2 min read
• Genetown

  Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - May 04, 2023

  Syndax Pharmaceuticals, Inc. announced that on May 1, 2023 the Company granted inducement awards to purchase up to 272,000 shares of common stock to fifteen new employees under the Company’s 2023 Inducement Plan.

  May 4, 2023

   · 

  1 min read
• Business

  Cryoport Reports First Quarter 2023 Results

  Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences, announced financial results for the three months ended March 31, 2023.

  May 4, 2023

   · 

  26 min read
• Business

  Protagonist Reports First Quarter 2023 Financial Results and Provides Corporate Update

  Protagonist Therapeutics reported financial results for the first quarter ended March 31, 2023, and provided a corporate update.

  May 4, 2023

   · 

  10 min read
• Business

  Cerus Corporation Announces First Quarter 2023 Financial Results

  Cerus Corporation announced financial results for the first quarter ended March 31, 2023.

  May 4, 2023

   · 

  17 min read